passiv
immun
provid
anim
sever
sourc
antibodi
includ
colostrum
avian
egg
monoclon
sourc
antibodi
shown
protect
product
companion
anim
number
pathogen
chapter
review
immun
system
principl
immun
respons
antigen
synthesi
immunoglobulin
five
class
antibodi
bodi
colostrum
antibodi
describ
passiv
immun
protect
anim
calv
chicken
egg
antibodi
anoth
sourc
antibodi
passiv
immun
therapeut
monoclon
antibodi
also
use
provid
passiv
immun
veterinari
field
use
antibodi
veterinarian
maintain
health
anim
long
histori
fundament
come
immun
system
health
product
companion
anim
littl
absolut
differ
intend
purpos
immun
system
mammal
basic
immun
system
minor
differ
speci
even
differ
bird
mammal
great
sinc
purpos
immun
system
keep
infecti
microorgan
certain
bacteria
virus
fungi
bodi
destroy
infecti
microorgan
invad
bodi
veterinarian
take
advantag
immun
system
maintain
health
roughli
defin
take
advantag
bodi
inher
method
maintain
health
adapt
immun
provid
vaccin
gener
antibodi
insid
anim
administ
preform
antibodi
anim
process
call
passiv
immun
evolut
produc
amaz
immun
system
anim
util
variou
cell
type
protein
protect
invas
organ
system
two
broad
categori
nonadapt
adapt
nonadapt
immun
system
mediat
cell
respond
nonspecif
manner
foreign
substanc
respons
includ
phagocytosi
macrophag
secret
lysozym
lacrim
cell
cell
lysi
natur
killer
cell
adapt
immun
respons
mediat
lymphocyt
produc
set
protein
call
antibodi
either
secret
found
surfac
lymphocyt
antibodi
creat
within
anim
follow
vaccin
exposur
pathogen
process
call
adapt
immun
preform
antibodi
host
anim
given
anoth
recipi
anim
offspr
even
complet
differ
speci
anim
process
call
passiv
immun
scientist
long
taken
advantag
adapt
immun
system
use
vaccin
vaccin
anim
diseas
first
result
laboratorybas
scientif
investig
french
chemist
loui
pasteur
develop
vaccin
chicken
cholera
one
anthrax
sheep
cattl
major
goal
veterinari
vaccin
improv
health
welfar
companion
anim
increas
product
livestock
costeffect
manner
prevent
animaltohuman
transmiss
domest
anim
wildlif
divers
aim
led
differ
approach
develop
veterinari
vaccin
crude
effect
wholepathogen
prepar
molecularli
defin
subunit
vaccin
genet
engin
organ
chimera
vector
antigen
formul
nake
dna
inject
meeusen
et
al
also
result
variou
guidelin
vaccin
companion
anim
dog
ford
et
al
product
anim
swine
alabama
auburn
poultri
stewartbrown
cowcalf
missouri
product
anim
success
veterinari
vaccin
produc
viral
bacteri
protozo
multicellular
pathogen
mani
way
led
field
applic
adapt
novel
technolog
passiv
immun
wherea
activ
immun
refer
process
expos
individu
antigen
gener
adapt
immun
respons
passiv
immun
refer
transfer
antibodi
one
individu
anoth
marcott
passiv
immun
provid
shortliv
protect
last
sever
week
month
immedi
natur
intend
passiv
immun
occur
matern
antibodi
transfer
fetu
placenta
breast
milk
gut
infant
howev
also
produc
artifici
antibodi
prepar
deriv
sera
secret
immun
donor
deliv
via
oral
system
rout
nonimmun
individu
passiv
immun
new
approach
provid
protect
anim
pathogen
emerg
new
drugresist
microorgan
diseas
unrespons
drug
therapi
individu
impair
immun
system
unabl
respond
convent
vaccin
immun
system
respond
specif
million
differ
molecul
constantli
challeng
huge
number
antigen
major
featur
immun
system
synthes
vast
number
antibodi
antibodi
bind
differ
antigen
bind
basi
molecular
specif
immun
respons
antibodi
protein
produc
type
termin
differenti
b
lymphocyt
b
cell
take
b
name
chicken
bursa
cell
first
discov
gitlin
nussenzweig
antibodi
produc
respons
presenc
foreign
molecul
bodi
antibodi
circul
throughout
blood
lymph
bind
foreign
antigen
bound
antibodyantigen
complex
remov
circul
primarili
phagocytosi
macrophag
basi
antibodi
protect
anim
pathogen
antibodi
larg
famili
glycoprotein
share
key
structur
function
featur
structur
standpoint
antibodi
look
like
yshape
molecul
fig
contain
four
polypeptid
two
polypeptid
ident
call
heavi
chain
two
also
ident
call
light
chain
connect
disulfid
bond
five
class
antibodi
igg
igm
iga
ige
igd
classifi
base
number
ylike
unit
type
heavychain
polypeptid
contain
fig
igm
largest
antibodi
first
appear
respons
initi
antigen
exposur
spleen
plasma
cell
respons
antibodi
product
resid
major
site
specif
igm
product
capolunghi
et
al
marchaloni
et
al
igg
main
type
antibodi
found
blood
extracellular
fluid
allow
fig
antibodi
structur
drawn
protein
model
electron
microscopi
control
infect
within
bodi
tissu
approxim
antibodi
human
companion
anim
igg
class
immunoglobulin
iga
play
crucial
role
immun
function
mucou
membran
amount
iga
produc
associ
mucos
membran
greater
type
antibodi
combin
fagarasan
honjo
holmgren
czerkinski
snoeck
et
al
igd
initi
thought
recent
evolv
antibodi
class
detect
primat
mice
rat
dog
guinea
pig
swine
cattl
sheep
frog
preudhomm
et
al
howev
recent
discoveri
igd
ancient
vertebr
suggest
igd
preserv
evolut
fish
human
import
immunolog
function
chen
cerutt
immunoglobulin
e
ige
identifi
mammal
ige
main
function
immun
parasit
helminth
erb
like
schistosoma
mansoni
trichinella
spirali
fasciola
hepatica
watanab
et
al
pfister
et
al
ige
also
essenti
role
type
hypersensit
gould
et
al
manifest
variou
allerg
diseas
allerg
asthma
type
sinus
allerg
rhiniti
food
allergi
specif
type
chronic
urticaria
atop
dermat
mueller
et
al
antibodi
bind
antigen
upper
tip
molecul
region
antigen
bind
occur
call
epitop
fig
antibodi
bind
wide
rang
chemic
structur
discrimin
among
relat
compound
well
antibodi
bind
antigen
known
affin
affin
rang
low
high
colostrum
passiv
immun
mammal
born
without
fulli
function
adapt
immun
system
even
though
basic
element
present
mammal
born
emerg
steril
uteru
environ
immedi
expos
host
microorgan
gastrointestin
tract
git
acquir
complex
microbi
flora
within
hour
surviv
newborn
anim
must
abl
control
microbi
invas
practic
adapt
immun
system
take
time
becom
fulli
function
innat
mechan
respons
initi
resist
infect
speci
short
gestat
period
mice
adapt
immun
system
may
even
fulli
develop
birth
anim
long
gestat
period
domest
mammal
adapt
immun
system
fulli
develop
birth
function
adult
level
sever
week
complet
develop
activ
immun
depend
antigen
stimul
proper
develop
b
cell
bcell
receptor
divers
requir
clonal
select
antigendriven
cell
multipl
thu
newborn
mammal
vulner
infect
first
week
life
need
assist
defend
junctur
temporari
help
provid
mother
form
colostrum
contain
antibodi
passiv
transfer
immun
mother
newborn
essenti
surviv
calv
born
without
activ
immun
system
reli
consumpt
antibodi
protect
diseas
scour
pneumonia
cow
provid
calf
nutrient
growth
develop
gestat
cow
directli
provid
calf
antibodi
protect
diseas
fortun
immunoglobulin
form
import
compon
immunolog
activ
found
milk
colostrum
human
larg
amount
iga
colostrum
colostrum
anim
contain
high
percentag
igg
hurley
theil
fig
immunoglobulin
found
mammari
secret
aris
system
local
sourc
case
igm
iga
ige
igd
igg
milk
major
portion
come
serum
mayer
et
al
plasma
cell
produc
igg
may
occur
within
mammari
tissu
contribut
igg
colostrum
minor
compar
igg
deriv
serum
major
class
immunoglobulin
transport
colostrum
milk
iga
igm
immunoglobulin
iga
major
immunoglobulin
human
colostrum
milk
howev
also
present
milk
speci
colostrum
milk
iga
igm
found
form
secretori
iga
siga
sigm
much
produc
plasma
cell
mammari
tissu
plasma
cell
part
gutassoci
lymphoid
tissu
galt
largest
immun
organ
organ
includ
peyer
patch
lymphoid
myeloid
cell
lamina
propria
intraepitheli
lymphocyt
ishikawa
et
al
interestingli
enough
immun
system
locat
gastro
intestin
tract
site
mani
oral
pathogen
first
interact
anim
vighi
et
al
galt
part
mucosaassoci
lymphoid
tissu
work
immun
system
protect
anim
invas
pathogen
gut
one
physiolog
function
mucosa
gut
food
absorpt
howev
equal
import
galt
bodi
defens
due
larg
popul
plasma
cell
whose
number
exce
number
plasma
cell
spleen
lymph
node
bone
marrow
combin
nagleranderson
lymphocyt
galt
system
move
mammari
gland
provid
direct
link
antigen
exposur
respons
mother
mucosa
system
secretori
immunoglobulin
mammari
gland
brandtzaeg
mean
matern
colostrum
milk
contain
antibodi
specif
pathogen
may
encount
neonat
intestin
mucos
tissu
provid
rational
observ
bovin
colostrum
nonimmun
cow
may
also
afford
passiv
immun
protect
human
pathogen
human
anim
lichan
et
al
yolken
et
al
open
door
new
technolog
provid
veterinarian
anoth
way
protect
anim
pathogen
involv
antibiot
antibodi
must
obtain
drink
colostrum
within
first
coupl
hour
birth
part
passiv
immun
system
order
maxim
antibodi
absorpt
pakkanen
aalto
like
anim
antibodi
gener
healthi
cow
result
everi
day
exposur
infecti
agent
antibodi
also
result
specif
vaccin
program
cow
natur
antibodi
infecti
agent
pass
cow
calf
colostrum
level
antibodi
transmit
cow
colostrum
elev
precalv
vaccin
program
thoma
calf
drink
colostrum
matern
deriv
antibodi
absorb
calf
git
blood
stream
immunoglobulin
also
remain
gut
neutral
pathogen
bacteria
help
prevent
develop
diarrhea
absorpt
antibodi
git
bloodstream
call
passiv
transfer
failur
passiv
transfer
fpt
dairi
calv
defin
blood
igg
level
mgml
h
birth
stilwel
carvalho
calv
experi
fpt
like
becom
sick
die
first
month
life
calv
adequ
immun
mani
factor
contribut
fpt
colostrum
manag
colostrum
feed
often
involv
success
obtain
passiv
transfer
provid
calf
protect
diseas
thought
calf
need
consum
minimum
g
immunoglobulin
meganck
et
al
pathway
gastrointestin
tract
bloodstream
open
short
window
time
research
show
pathway
start
close
shortli
birth
h
approxim
calf
abil
absorb
colostrum
antibodi
gone
therefor
recommend
feed
calv
much
colostrum
want
bottl
within
h
birth
h
age
substanti
reduc
probabl
fpt
chigerw
et
al
trotzwilliam
et
al
colostrum
also
provid
calf
protein
energi
form
fat
sugar
vitamin
quigley
drewri
vitamin
cross
placent
barrier
colostrum
primari
sourc
nutrient
calf
birth
energi
requir
metabol
function
includ
mainten
bodi
temperatur
one
lead
caus
death
dairi
calv
failur
initi
breath
metabol
process
first
hour
life
newborn
calf
hour
energi
reserv
store
fat
therefor
need
energi
colostrum
research
also
confirm
sooner
calf
consum
colostrum
matern
antibodi
util
qualiti
colostrum
major
issu
dairi
industri
face
regular
basi
gener
speak
qualiti
colostrum
relat
amount
antibodi
present
colostr
igg
concentr
import
factor
affect
whether
calv
receiv
suffici
passiv
immun
godden
et
al
unfortun
amount
igg
matern
colostrum
vari
dramat
among
cow
gl
sampl
reach
desir
amount
g
iggl
gulliksen
et
al
colostr
qualiti
difficult
estim
farmer
base
produc
volum
appear
colostrum
mani
variabl
impact
colostrum
qualiti
includ
nutrit
time
cow
milk
heat
stress
stage
lactat
studi
iowa
state
univers
suggest
minimum
dairi
calv
usa
current
fed
colostrum
classifi
industri
standard
igg
content
greater
risk
fpt
mortal
morbid
morril
et
al
product
mammal
piglet
face
issu
calv
colostrum
qualiti
studi
shown
averag
pig
colostrum
intak
g
usual
die
pig
colostrum
intak
g
mortal
high
devil
et
al
give
spraydri
bovin
colostrum
anim
piglet
shown
sti
et
al
help
protect
gut
dysfunct
inflamm
may
possibl
use
bovin
colostrum
piglet
could
help
supplement
sow
colostrum
research
also
done
foal
enhanc
bovin
colostrum
supplement
fenger
et
al
sinc
cow
colostrum
igg
level
mgml
prevent
fpt
varieti
program
protocol
implement
dairi
produc
highqual
matern
colostrum
still
gold
standard
feed
newborn
calv
howev
colostrum
supplement
replac
product
valuabl
tool
increas
calf
immun
colostrum
suppli
limit
diseas
erad
desir
colostrum
product
contain
igg
regul
usda
center
veterinari
biolog
avail
bolu
gel
powder
format
supplement
product
unabl
rais
blood
concentr
igg
speci
standard
mgml
calv
product
abl
rais
serum
igg
concentr
mgml
may
call
colostrum
replac
penn
state
supplement
contain
suffici
quantiti
antibodi
rais
blood
igg
level
calv
beyond
averag
qualiti
colostrum
colostrum
replac
contain
greater
level
igg
nutrient
provid
effect
conveni
method
provid
passiv
immun
calv
matern
colostrum
avail
colostrum
supplement
avail
today
made
dri
bovin
colostrum
serum
contain
g
igg
per
dose
globulin
protein
fat
content
product
rang
spraydri
colostrum
high
concentr
immunoglobulin
may
produc
econom
use
effect
conveni
colostrum
replac
newborn
calv
chelack
et
al
numer
product
design
replac
colostrum
market
product
made
bovin
colostrum
serum
contain
g
igg
per
dose
product
also
provid
fat
protein
vitamin
miner
need
newborn
calf
although
amount
vari
product
summari
pennsylvania
state
univers
treatment
mean
publish
studi
investig
colostrum
product
indic
replac
product
provid
averag
g
igg
absorpt
effici
serum
igg
mgml
supplement
product
fed
addit
colostrum
provid
g
igg
absorpt
effici
result
serum
igg
mgml
recogn
antibodi
found
colostrum
certainli
reduc
diseas
anim
via
passiv
immun
given
newborn
work
colostrum
donor
anim
expos
either
natur
diseas
given
vaccin
diseas
order
specif
antibodi
produc
bovin
colostrum
typic
spraydri
supplement
replac
contain
antibodi
cow
may
encount
natur
therefor
colostrum
use
may
specif
antibodi
particular
diseas
produc
might
interest
anim
industri
recogn
issu
develop
method
produc
specif
antibodi
high
titer
specif
diseas
deliv
colostrum
product
achiev
hyperimmun
anim
cow
specif
anim
diseas
collect
colostrum
process
powder
freezedri
method
give
newborn
anim
gel
bolus
number
diseas
includ
bacteri
diseas
like
e
coli
selim
et
al
viral
diseas
rotaviru
coronaviru
comb
et
al
coccidi
diseas
giardia
cryptosporidia
graczyk
et
al
fayer
et
al
naciri
et
al
research
hyperimmun
colostrum
efficaci
hyperimmun
colostrum
collect
process
given
newborn
calv
vari
degre
success
hyperimmun
colostrum
antibodi
proven
success
provid
passiv
immun
besid
calv
research
done
varieti
product
anim
use
bovin
sourc
colostrum
exampl
lamb
supplement
ewe
colostrum
well
hyperimmun
serum
sheep
e
coli
pommer
research
examin
vaccin
cow
clostridi
antigen
passiv
transfer
clostridi
antibodi
bovin
colostrum
lamb
clarkson
et
al
piglet
also
given
passiv
protect
porcin
epidem
diarrhea
hyperimmun
bovin
colostrum
shibata
et
al
specif
antibodi
hyperimmun
colostrumderiv
product
use
complement
earli
colostrum
feed
deliv
time
colostrum
advantag
strategi
specif
immunoglobulin
immedi
fight
gut
level
protect
diseas
destroy
intestin
line
also
allow
antibodi
absorb
bloodstream
import
protect
intestin
line
cell
line
digest
tract
becom
damag
milk
digest
absorb
calf
besid
qualiti
colostrum
research
first
believ
calv
could
vaccin
effect
circul
matern
antibodi
colostrum
system
prewean
calv
respond
vaccin
stimul
earli
month
age
matern
antibodi
absorb
colostrum
howev
distinguish
antigen
natur
challeng
antigen
vaccin
therefor
colostrum
antibodi
interfer
immun
respons
vaccin
niewiesk
work
continu
done
develop
way
circumv
matern
antibodi
interfer
vaccin
calv
face
matern
antibodi
ifoma
often
result
seroconvers
matern
deriv
immun
interfer
activ
adequ
antibodi
respons
vaccin
howev
prime
tand
bcell
memori
respons
protect
calv
clinic
diseas
matern
immun
decay
activ
band
tcell
memori
respons
calv
vaccin
ifoma
vari
affect
sever
factor
includ
age
level
matern
immun
type
vaccin
rout
administr
factor
influenc
adequ
prime
humor
cellmedi
immun
respons
outcom
vaccin
failur
adequ
prime
immun
memori
vaccin
ifoma
could
result
lack
clinic
protect
increas
risk
viremia
andor
viru
shed
chamorro
et
al
obvious
controversi
whether
newborn
calv
vaccin
cook
et
al
thought
process
calf
mount
immun
respons
vaccin
requir
energi
could
better
use
fight
diseas
gain
weight
respons
could
actual
detriment
earli
health
calf
hand
matern
antibodi
block
respons
vaccin
sometim
woolum
exact
immunolog
outcom
calv
vaccin
ifoma
vari
variat
like
depend
mani
factor
factor
well
character
like
includ
natur
vaccin
administ
number
dose
administ
age
calf
level
matern
antibodi
present
calf
mean
protect
respons
defin
guidelin
vaccin
newborn
anim
calv
requir
addit
research
clarifi
ifoma
vaccin
reaction
fortun
produc
also
option
use
antibodi
product
order
gener
immedi
protect
situat
colostrum
qualiti
poor
antibodi
product
complement
colostrum
feed
fed
time
product
avail
bolu
gel
powder
form
also
includ
colostrum
replac
supplement
formula
ad
valu
typic
antibodi
product
hyperimmun
cow
specif
antibodi
found
colostrum
colostrum
process
typic
fraction
semipurifi
prepar
antibodi
freezedri
put
capsul
bolus
antibodi
bolus
fed
conjunct
colostrum
tool
help
calf
achiev
adequ
passiv
transfer
also
provid
enough
specif
antibodi
protect
common
earli
calf
hood
diseas
antibodi
product
requir
calf
react
vaccin
order
develop
antibodi
rather
specif
antibodi
variou
diseas
alreadi
present
measur
verifi
high
enough
level
protect
calf
scourrel
diseas
fed
close
birth
possibl
unit
state
depart
agricultur
usda
approv
antibodi
product
avail
market
fed
conjunct
colostrum
provid
calf
immedi
immun
antibodi
go
gut
immedi
bind
neutral
diarrhea
antigen
also
absorb
blood
stream
extend
protect
comb
et
al
chamorro
et
al
anoth
advantag
approach
provid
specif
antibodi
potenti
avoid
vaccin
stimul
avoid
vaccin
stimul
allow
calf
conserv
minim
suppli
fat
nutrient
critic
get
calf
first
day
life
passiv
immun
egg
antibodi
cow
pass
immun
offspr
colostrum
variou
colostrum
product
market
achiev
passiv
immun
addit
sourc
antibodi
product
util
similar
manner
achiev
passiv
immun
avian
sourc
chicken
bird
passiv
transfer
immun
occur
egg
hyperimmun
chicken
period
time
inactiv
multival
bacteri
viral
vaccin
procedur
result
product
polyclon
immunoglobulin
igi
class
specif
avian
direct
stimul
organ
oral
consumpt
immun
egg
contain
specif
igi
antibodi
protect
anim
specif
organ
hen
stimul
unfortun
egg
realli
cook
sinc
heat
dentur
antibodi
found
egg
physic
paramet
acid
ph
also
destroy
antibodi
certain
extent
howev
enough
oral
administr
igi
may
surviv
passag
git
excret
still
retain
great
deal
antigenbind
abil
indic
oral
administr
igi
use
passiv
immun
egg
natur
sourc
immunoregulatori
factor
immun
protect
transfer
utero
mammal
passiv
lactat
mother
via
colostrum
hen
passiv
transfer
protect
young
secret
immunoglobulin
immun
factor
egg
use
hatch
chick
transfer
chicken
immunoglobulin
hen
serum
yolk
yolk
chick
analog
crossplacent
transfer
igg
mammalian
mother
offspr
igm
iga
found
chicken
egg
principl
immunoglobulin
igi
found
yolk
egg
hamal
et
al
igi
stand
yolk
immunoglobulin
class
specif
avian
analog
function
mammalian
immunoglobulin
igi
similar
structur
mammalian
igg
minor
differ
heavi
chain
fig
egg
milk
includ
breast
milk
contain
natur
occur
antibodi
report
immunomodulatori
factor
milk
well
li
et
al
howev
immunoglobulin
level
egg
significantli
higher
level
found
serum
milk
woolley
landon
may
surpris
sinc
mammal
consider
longer
time
week
month
may
passiv
transfer
immunoglobulin
immun
factor
hen
singl
opportun
egg
transfer
necessari
surviv
compon
offspr
aspect
chick
need
surviv
must
egg
egg
product
common
sourc
protein
human
diet
egg
contain
antibodi
immun
factor
obviou
util
egg
antibodi
provid
passiv
immun
anim
result
number
commerci
egg
antibodi
product
market
product
anim
well
companion
anim
prevent
variou
diseas
except
oral
consumpt
specif
antibodi
report
diraviyam
et
al
protect
human
anim
furthermor
vitro
studi
specif
igi
antibodi
found
inhibit
process
associ
bacteri
growth
adhes
intestin
cell
toxin
product
sugitakonishi
et
al
metaanalysi
demonstr
benefici
effect
igi
diraviyam
et
al
varieti
anim
fig
structur
mammalian
igg
compar
avian
igi
analysi
support
opinion
igi
use
prophylaxi
treatment
current
oral
passiv
immun
use
chicken
igi
focus
altern
antibiot
treatment
control
diarrhea
igi
demonstr
effect
control
prevent
diarrhea
human
anim
includ
piglet
cui
et
al
vega
et
al
mice
buragohain
et
al
poultri
elghani
farooq
et
al
calv
cook
et
al
germin
et
al
vega
et
al
commerci
avail
chicken
immun
birth
protect
avian
diseas
differ
supermarket
egg
immun
egg
latter
chicken
receiv
addit
proprietari
vaccin
inactiv
pathogen
known
etiolog
agent
anim
infect
wide
rang
bacteria
virus
coccidia
use
vaccin
produc
commerci
igi
product
partial
list
includ
shigella
dysenteria
staphylococcu
epidermidi
escherichia
coli
e
coli
salmonella
enteritidi
typhimurium
pseudomona
aeruginosa
klebsiella
pneumonia
haemophilu
influenza
speci
streptococcu
salmonella
dublin
salmonella
anatum
clostridium
perfringen
type
type
c
toxoid
rotaviru
type
coronaviru
reoviru
parvoviru
cryptosporidium
parvum
schade
et
al
chicken
egg
expos
inactiv
pathogen
immunoglobulin
immun
factor
passiv
transfer
egg
serum
use
chick
importantli
passiv
immun
anim
appropri
time
follow
vaccin
egg
collect
special
design
chicken
flock
wash
broken
yolk
egg
white
typic
dri
fine
proteinac
powder
variou
process
develop
help
minim
heat
damag
egg
antibodi
immunoregulatori
factor
spraydri
procedur
howev
spraydri
egg
denatur
igi
extent
due
least
heat
process
keep
egg
away
heat
optim
way
maintain
igi
titer
level
efficaci
freezedri
expens
option
maintain
antibodi
titer
level
simpli
feed
fresh
immun
egg
anoth
method
exist
keep
immun
egg
stabil
liquid
dubourdieu
stabil
liquid
format
practic
inexpens
deliveri
method
allow
specif
igi
deliv
water
system
product
anim
incorpor
deliveri
format
soft
chew
readili
given
companion
anim
fig
effect
mechan
avian
igi
work
effect
mechan
mammalian
igg
antibodi
work
anim
provid
passiv
immun
exampl
bacteria
e
coli
strain
typic
caus
problem
product
anim
result
diarrhea
possibl
death
therefor
vaccin
program
use
chicken
creat
specif
anti
coli
igi
antibodi
specif
antibodi
found
yolk
egg
given
oral
anim
prevent
e
coli
caus
diseas
occur
specif
anti
coli
igi
antibodi
bind
pathogen
bacteria
bind
block
abil
pathogen
bind
mucin
layer
obtain
egg
yolk
contain
specif
igi
antigen
spray
dri
powder
contain
specif
igi
stabil
liquid
contain
specif
igi
fig
vaccin
specif
antibodi
process
egg
yolk
strategi
gi
tract
anim
pathogen
flush
gi
tract
fece
sinc
render
unabl
bind
total
immunoglobulin
content
egg
hyperimmun
hen
ident
total
level
immunoglobulin
found
convent
tabl
egg
howev
quantiti
immunoglobulin
select
antigen
differ
two
varieti
egg
addit
tabl
egg
immun
egg
contain
immunoregulatori
factor
egg
hyperimmun
chicken
may
contain
mani
time
greater
concentr
individu
factor
compar
regular
egg
besid
immunoglobulin
egg
contain
number
bioactiv
compon
includ
phospholipid
cholesterol
lutein
zeaxanthin
protein
possess
varieti
proandor
antiinflammatori
properti
two
major
categori
immun
compon
found
hyperimmun
egg
immunoglobulin
neutral
specif
stimul
pathogen
immunoregulatori
factor
modul
cellular
function
immunoglobulin
provid
local
protect
gastrointestin
intox
immunomodulatori
mediat
act
directli
gastrointestin
surfac
circul
system
affect
everi
immun
physic
metabol
neuroendocrin
pathway
bodi
may
import
implic
pathophysiolog
numer
chronic
diseas
immun
respons
acut
injuri
andersen
given
essenti
proinflammatori
respons
normal
immun
defens
pathogen
research
role
egg
intak
immun
warrant
may
lead
commerci
use
egg
igi
technolog
biolog
medicin
human
intervent
pioneer
last
year
horizon
companion
anim
strategi
includ
use
monoclon
antibodi
mab
select
target
protein
cellular
receptor
solubl
molecul
involv
diseas
pathogenesi
treatment
hold
potenti
target
therapi
chronic
diseas
osteoarthr
atop
dermat
lymphoma
dog
cat
monoclon
antibodi
antibodi
made
ident
immun
cell
clone
uniqu
parent
cell
monoclon
antibodi
monoval
affin
bind
epitop
contrast
polyclon
antibodi
bind
multipl
epitop
usual
made
sever
differ
plasma
cell
lineag
fig
given
almost
substanc
possibl
produc
monoclon
antibodi
specif
bind
substanc
serv
detect
purifi
substanc
becom
import
tool
biochemistri
molecular
biolog
medicin
therapeut
mab
use
medic
block
diseaserelev
protein
eg
cytokin
receptor
cell
cancer
gain
signific
use
human
also
use
target
virus
bacteria
aid
destruct
elimin
veterinari
medicin
incorpor
tool
despit
success
mab
human
medicin
consider
fewer
pipelin
veterinari
medicin
may
due
uncertain
regulatori
guidanc
europ
usa
regulatori
document
written
perspect
human
medicinebas
risk
assess
develop
recogn
may
present
challeng
veterinari
mab
manufactur
achiev
extent
characterizationqu
control
test
typic
requir
human
mab
ema
regardless
pet
medicin
industri
make
stride
put
mab
market
basic
research
earli
human
therapeut
mab
contain
high
proport
mousederiv
sequenc
fulli
mous
mous
human
chimer
mab
recogn
human
immun
system
foreign
immun
respons
trigger
product
antimab
lead
reduc
therapeut
efficaci
subsequ
design
human
fulli
human
mab
result
vast
reduct
immunogen
although
therapeut
mab
may
remain
immunogen
follow
appar
advers
clinic
manifest
issu
hold
true
antigen
polyclon
antibodi
antigen
monoclon
antibodi
fig
polyclon
antibodi
compar
monoclon
antibodi
bind
antigen
make
veterinari
mab
util
canin
mab
dog
help
efficaci
found
canin
antiig
mab
reduc
ige
hypersensit
mitesensit
beagl
gear
et
al
canin
antinerv
growth
factor
mab
webster
significantli
reduc
pain
score
webster
et
al
dog
mab
neutral
pruritogen
cytokin
dog
reduc
prurit
respons
week
inject
dunham
et
al
one
aspect
regard
commerci
therapeut
antibodi
involv
regul
usda
two
usdaapprov
monoclon
antibodi
treatment
bcell
tcell
lymphoma
dog
grant
mab
fight
lymphoma
target
protein
commonli
express
bcell
lymphoma
ogilvi
et
al
bulmanflem
et
al
particular
mab
commerci
success
part
new
approach
use
therapeut
antibodi
veterinari
medicin
compani
develop
veterinari
mab
cancer
allergi
chronic
inflammatori
diseas
atop
dermat
control
pain
associ
osteoarthr
dog
cat
webster
et
al
first
mab
approv
veterinari
use
european
union
bmj
treat
clinic
sign
atop
dermat
dog
includ
itch
inflamm
month
mab
treatment
work
mimick
activ
natur
antibodi
select
bind
neutral
key
protein
involv
cell
commun
trigger
itch
associ
atop
dermat
dog
neutral
demonstr
interfer
immun
respons
mean
induc
unintend
immunosuppress
enhanc
therapeut
mab
deliv
via
intraven
intramuscular
subcutan
inject
antibodi
ca
nt
deliv
oral
breakdown
stomach
acid
factor
found
variou
encapsul
methodolog
requir
order
overcom
basic
issu
method
forthcom
inject
therapeut
mab
like
natur
antibodi
long
halflif
day
absolut
halflif
uniqu
depend
upon
concentr
distribut
target
mab
direct
cellsurfac
receptor
clearanc
elimin
target
receptor
therapeut
mab
two
main
safeti
advantag
specif
target
nt
intracellular
activ
result
anticip
side
effect
reaction
although
occur
catapanoab
papadopoulosc
mab
eventu
elimin
via
intracellular
catabol
lysosom
broken
peptid
amino
acid
either
reus
synthesi
new
protein
excret
via
urin
conclud
remark
futur
direct
antibodi
veterinari
use
great
potenti
futur
passiv
antibodi
therapi
treatment
infecti
diseas
concept
date
back
year
use
serum
immun
anim
provid
first
effect
treatment
option
infect
clostridium
tetani
corynebacterium
diphtheria
hey
howev
due
discoveri
penicillin
fleme
subsequ
introduct
much
cheaper
safer
antibiot
serum
therapi
larg
abandon
recent
time
broad
gener
use
antibiot
human
veterinari
medicin
result
develop
multiresist
strain
bacteria
limit
respons
exist
treatment
thu
need
altern
treatment
option
situat
partial
attribut
overus
antibiot
growth
promot
product
anim
indiscrimin
use
combin
specif
flexibl
antibodybas
treatment
provid
passiv
immun
make
valuabl
tool
design
specif
antibodi
treatment
infecti
agent
attribut
alreadi
caus
revolut
new
antibodybas
treatment
oncolog
inflammatori
diseas
mani
approv
product
human
use
howev
mab
approv
veterinari
use
mab
therapi
expens
barrier
develop
presenc
inexpens
antibiot
use
antibiot
growth
promot
came
end
usa
rest
world
alreadi
limit
use
purpos
manner
fda
open
door
new
technolog
antibodi
monoclon
sourc
chicken
egg
cow
colostrum
sourc
among
chief
contend
limit
diseas
safe
manner
potenti
act
growth
promot
purpos
antibodi
antibodyderiv
treatment
offer
attract
tool
attribut
neutral
infecti
agent
modul
immun
system
enabl
effector
cell
escap
immunosuppress
condit
contribut
elimin
infect
abil
rais
antibodi
target
abil
modul
effector
function
halflif
size
treatment
unit
make
antibodi
ideal
tailor
treatment
specif
infecti
agent
howev
research
use
antibodi
growth
promot
need
occur
one
area
research
look
make
better
use
antibodi
treatment
veterinari
use
includ
use
mab
predict
minim
amino
acid
chang
need
adapt
antibodi
one
speci
anoth
avoid
immun
reject
use
librari
genet
inform
algorithm
make
sure
key
amino
acid
sequenc
recogn
self
nativ
target
speci
immun
system
reduc
chanc
undesir
immun
reaction
increas
advantag
typic
mab
potenc
safeti
prolong
elimin
halflif
therefor
secondand
thirdgener
mab
forefront
veterinari
antibodi
technolog
along
igi
technolog
molecular
target
therapeut
mab
igi
colostrum
igg
anim
involv
clinic
sign
diseas
mechan
redund
pathway
compens
blockad
intend
target
valid
block
molecul
elimin
cell
type
must
also
weigh
import
protein
cell
desir
normal
bodi
function
possibl
specul
use
antibodi
companion
anim
might
includ
immunemedi
hemolyt
anemia
thrombopenia
myasthenia
gravi
autoimmun
blister
diseas
pemphigu
among
condit
cancer
use
mab
igi
therapi
target
blymphocyt
valuabl
bcell
lymphoma
dog
cat
allerg
diseas
use
mab
inhibit
product
ige
via
promot
cytokin
interleukin
cytokin
receptor
ige
might
benefici
dog
cat
igemedi
atop
dermat
food
allergi
itch
sensat
could
alter
least
theoret
antibodi
target
itchpromot
cytokin
nerv
growth
factor
thymic
stromal
lymphopoietin
neuromedi
involv
itch
transmiss
arthriti
therapeut
mab
inhibit
proinflammatori
cytokin
tnfalpha
etc
receptor
like
benefit
treat
dog
cat
arthriti
use
antingf
mab
analges
must
confirm
autoimmun
diseas
use
mab
specif
blymphocyt
surfac
protein
could
theoret
lead
reduc
product
autoantibodi
veterinari
vaccin
continu
major
impact
anim
health
product
also
human
health
increas
safe
food
suppli
prevent
animaltohuman
transmiss
infecti
diseas
continu
interact
anim
human
research
health
profession
major
import
adapt
new
technolog
provid
anim
model
diseas
confront
new
emerg
infecti
diseas
one
area
research
inform
need
factor
limit
efficaci
vaccin
ifoma
particularli
calv
month
old
complex
issu
howev
research
continu
evolv
area
newborn
calf
vaccin
passiv
immun
provid
chicken
egg
antibodi
gain
increas
use
product
anim
doubt
chicken
ab
produc
use
minor
modif
similar
way
mammalian
ab
also
said
depend
circumst
use
igi
ab
often
signific
advantag
use
mammalian
ab
howev
realist
point
view
igi
ab
probabl
abl
complet
replac
use
igg
ab
diagnost
system
near
futur
schade
et
al
chicken
potenti
use
complet
spectrum
anim
use
ab
product
howev
prerequisit
make
igi
technolog
popular
convinc
scientif
commun
signific
advantag
interest
possibl
futur
product
chicken
mab
would
combin
advantag
mab
advantag
chicken
ab
expect
studi
therapeut
prophylact
use
igi
ab
intensifi
futur
particular
increas
resist
microorgan
antibiot
research
aspect
relat
develop
specif
igi
pathogen
microorgan
intensifi
conclus
next
decad
see
continu
develop
therapeut
mab
igi
colostrum
antibodi
product
companion
anim
treatment
prevent
highli
specif
molecul
like
prove
benefici
uniqu
target
diseas
mechan
without
side
effect
associ
broadspectrum
pharmacotherapi
vaccin
continu
play
import
role
maintain
health
anim
activ
immun
antibodi
provid
passiv
immun
increas
part
arsen
avail
veterinarian
promot
growth
product
anim
safe
manner
maintain
health
companion
anim
